Human Formulations

Vildagliptin 50MG Tablet (Uncoated Tablet)

Vildagliptin 50MG Tablet (Uncoated Tablet) is a tablet formulated with Vildagliptin 50MG ( ). The listed active ingredient profile is Vildagliptin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lo

Therapeutic RangesDiabetic Range Single Ingredient Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Therapeutic Ranges, Diabetic Range
Dosage Form
Tablet
Product Type
Single Ingredient

Available strengths

Vildagliptin 50MG ( )

Description

Vildagliptin 50MG Tablet (Uncoated Tablet) is a tablet formulated with Vildagliptin 50MG ( ). The listed active ingredient profile is Vildagliptin, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering medicines used in clinician-directed management of type 2 diabetes mellitus. The source identifies the dosage form as tablet with uncoated presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured